LIGAND PHARMACEUTICALS INC CON
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for LIGAND PHARMACEUTICALS INC CON COM, CUSIP 532CNT029.
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for LIGAND PHARMACEUTICALS INC CON COM, CUSIP 532CNT029.